İlaçların Uygulama Yolları ve Doz Hesaplamaları
Özet
Veteriner hekimlikte ilaçların doğru uygulanması ve güvenli dozlanması, tedavi başarısının temel belirleyicilerindendir. İlaç seçiminin yanı sıra uygulama yolu ve dozaj rejiminin doğru planlanması, terapötik etkinliğin sağlanması ve advers etkilerin önlenmesi açısından kritik öneme sahiptir. Bu bölümde, ilaçların enteral, parenteral, topikal ve inhalasyon yoluyla uygulanmasına ilişkin temel ilkeler sistematik biçimde ele alınmıştır. Her uygulama yolunun farmakokinetik özellikleri, avantajları, sınırlılıkları ve klinik kullanım alanları karşılaştırmalı olarak değerlendirilmiştir. Doz hesaplamalarının temel prensipleri; canlı ağırlığa dayalı doz belirleme, konsantrasyon dönüşümleri, yüzde çözelti yorumlama, ünite (IU) içeren preparatların hesaplanması, infüzyon hızlarının belirlenmesi ve seyreltme işlemleri çerçevesinde ayrıntılı olarak açıklanmıştır. Ayrıca türler arası farmakokinetik farklılıklar, yaş, gebelik, laktasyon ve organ yetmezlikleri gibi klinik değişkenlerin doz ayarlamalarına etkisi tartışılmıştır. Gıda hayvanlarında ilaç kullanımı ise kalıntı riski ve yasal düzenlemeler açısından ele alınmıştır. Bölüm boyunca, sık yapılan doz ve uygulama hataları ile bu hataların önlenmesine yönelik sistematik kontrol yaklaşımları vurgulanmıştır. Sunulan kavramsal çerçeve ve çözümlü örnek vakalar, veteriner hekimlik pratiğinde güvenli ve rasyonel ilaç kullanımını desteklemeyi amaçlamaktadır.
The correct administration and safe dosing of drugs are fundamental determinants of therapeutic success in veterinary medicine. In addition to appropriate drug selection, the choice of administration route and accurate dosage regimen planning are critical for achieving optimal therapeutic outcomes and minimizing adverse effects. This chapter systematically addresses the principal routes of drug administration in veterinary practice, including enteral, parenteral, topical, and inhalational routes. The pharmacokinetic characteristics, advantages, limitations, and clinical indications of each route are comparatively evaluated. The fundamental principles of dose calculation are explained in detail, including body weight–based dosing, concentration conversions, interpretation of percentage solutions, handling of international unit (IU)–based preparations, infusion rate calculations, and dilution procedures. Furthermore, the impact of interspecies pharmacokinetic differences, age, pregnancy, lactation, and organ dysfunction on dose adjustments is discussed. Special considerations for food-producing animals are also addressed, particularly in relation to drug residues and regulatory compliance. Common medication errors in veterinary practice, including unit miscalculations, incorrect route selection, and dilution mistakes, are highlighted, together with systematic strategies for error prevention. The conceptual framework and step-by-step case examples presented in this chapter aim to promote rational drug use and enhance medication safety in clinical veterinary practice.
Referanslar
Assiri GA, Shebl NA, Mahmoud MA, et al. What is the epidemiology of medication errors, error-related adverse events and risk factors for errors in adults managed in community care contexts? A systematic review of the international literature. BMJ Open. 2018;8(5): e019101.
Brown, M. B., Martin, G. P., Jones, S. A., & Akomeah, F. K. (2006). Dermal and transdermal drug delivery systems: current and future prospects. Drug delivery, 13(3), 175-187.
Brunton LL, Knollmann BC, Hilal-Dandan R (eds.) Goodman & Gilman's the pharmacological basis of therapeutics. 13th ed. New York: McGraw-Hill Education; 2018.
Brunton, L. L., Knollmann, B. C., & Hilal-Dandan, R. (Eds.). (2018). Goodman & Gilman's the pharmacological basis of therapeutics (Vol. 13). New York: McGraw-Hill Education.
Codex Alimentarius Commission. Maximum residue limits for veterinary drugs in foods. FAO/WHO; 2021. Available from: https://www.fao.org/fao-who-codexalimentarius/
European Medicines Agency. Maximum residue limits and withdrawal periods for veterinary medicinal products. 2022. Available from: https://www.ema.europa.eu/
Hardee GE, Baggo JD. Development and formulation of veterinary dosage forms. Boca Raton: CRC Press; 2021.
Hedaya MA. Routes of drug administration. Hedaya MA (ed.) Pharmaceutics içinde. London: Academic Press; 2024. p. 537–554.
Kasabova S, Hartmann M, Werner N, et al. Used daily dose vs. defined daily dose—contrasting two different methods to measure antibiotic consumption at the farm level. Frontiers in Veterinary Science. 2019;6: 116.
Labiris NR, Dolovich MB. Pulmonary drug delivery. Part I: physiological factors affecting therapeutic effectiveness of aerosolized medications. British Journal of Clinical Pharmacology. 2003;56(6): 588–599.
Martinez M, Modric S. Patient variation in veterinary medicine: part I. Influence of altered physiological states. Journal of Veterinary Pharmacology and Therapeutics. 2010;33(3): 213–226.
Martinez MN, Amidon GL. A mechanistic approach to understanding the factors affecting drug absorption: a review of fundamentals. The Journal of Clinical Pharmacology. 2002;42(6): 620–643.
McIlwraith, C. W., Frisbie, D. D., & Kawcak, C. E. (2012). The horse as a model of naturally occurring osteoarthritis. Bone & joint research, 1(11), 297-309.
McKiernan BC. Therapeutic strategies involving antimicrobial treatment of the lower respiratory tract in small animals. Journal of the American Veterinary Medical Association. 1984;185(10): 1155–1158.
Nair AB, Jacob S. A simple practice guide for dose conversion between animals and human. Journal of Basic and Clinical Pharmacy. 2016;7(2): 27–31. doi:10.4103/0976-0105.177703
Padrid, P. (2006). Use of inhaled medications to treat respiratory diseases in dogs and cats. Journal of the American Animal Hospital Association, 42(2), 165-169.
Papich MG. Antimicrobial agent use in small animals: what are the prescribing practices, use of PK–PD principles, and extralabel use in the United States? Journal of Veterinary Pharmacology and Therapeutics. 2021;44(2): 238–249.
Papich MG. Drug compounding for veterinary patients. The AAPS Journal. 2005;7(2): 29.
Patel, V. F., Liu, F., & Brown, M. B. (2011). Advances in oral transmucosal drug delivery. Journal of Controlled Release, 153(2), 106–116.
Patton JS, Byron PR. Inhaling medicines: delivering drugs to the body through the lungs. Nature Reviews Drug Discovery. 2007;6(1): 67–74.atton, J. S., & Byron, P. R. (2007). Inhaling medicines: Delivering drugs to the body through the lungs. Nature Reviews Drug.
Reeves, P. T. (2007). Residues of veterinary drugs at injection sites. Journal of veterinary pharmacology and therapeutics, 30(1), 1-17.
Riviere JE, Papich MG (eds.) Veterinary pharmacology and therapeutics. Hoboken: John Wiley & Sons; 2018.
Rosati M. Saunders handbook of veterinary drugs: small and large animals. The Canadian Veterinary Journal. 2017;58(7): 728.
Rowland M, Tozer TN. Clinical pharmacokinetics and pharmacodynamics: concepts and applications. 4th ed. Philadelphia: Lippincott Williams & Wilkins; 2010.
Schoenwald RD. Ocular drug delivery: pharmacokinetic considerations. Clinical Pharmacokinetics. 1990;18(4): 255–269.
Toutain PL, Bousquet-Mélou A. Plasma clearance. Journal of Veterinary Pharmacology and Therapeutics. 2004;27(6): 415–425.
Toutain, P. L., & Lees, P. (2004). Integration and modelling of pharmacokinetic and pharmacodynamic data to optimize dosage regimens in veterinary medicine. Journal of veterinary pharmacology and therapeutics, 27(6), 467-477.
Toutain, P. L., & Lees, P. (2004). Integration and modelling of pharmacokinetic and pharmacodynamic data to optimize dosage regimens in veterinary medicine. Journal of veterinary pharmacology and therapeutics, 27(6), 467-477.
Urtti, A. (2006). Challenges and obstacles of ocular pharmacokinetics and drug delivery. Advanced drug delivery reviews, 58(11), 1131-1135.
Wallis J, Fletcher D, Bentley A, et al. Medical errors cause harm in veterinary hospitals. Frontiers in Veterinary Science. 2019;6: 12.
Westbrook JI, Woods A, Rob MI, et al. Association of interruptions with an increased risk and severity of medication administration errors. Archives of Internal Medicine. 2010;170(8): 683–690.
Wiegand S, Berner R, Schneider A, et al. Otitis externa: investigation and evidence-based treatment. Deutsches Ärzteblatt International. 2019;116(13): 224.
